Quick Answer
Legend Biotech Corp reported Total Assets of $1.73 billion for fiscal year 2025.
Legend Biotech Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $1.73B +3.8% |
$1.67B -9.7% |
$1.85B +38.9% |
$1.33B +18.9% |
$1.12B +55.3% |
$721.01M +150.6% |
| R&D Expense | $414.70M +0.3% |
$413.50M +8.2% |
$382.20M +13.9% |
$335.65M +7.1% |
$313.35M +35.0% |
$232.16M +43.4% |
- Legend Biotech Corp reported Total Assets of $1.73 billion for fiscal year 2025.
- Legend Biotech Corp showed an increase of +3.8% in Total Assets compared to the prior fiscal year.
- Legend Biotech Corp reported R&D Expense of $414.70 million for fiscal year 2025.
- Legend Biotech Corp showed an increase of +0.3% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: